These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain. De Salas-Cansado M; Olivares JM; Alvarez E; Carrasco JL; Barrueta A; Rejas J Clinicoecon Outcomes Res; 2012; 4():157-68. PubMed ID: 22745564 [TBL] [Abstract][Full Text] [Related]
3. The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder. Castagna PJ; Farahdel E; Potenza MN; Crowley MJ Expert Opin Pharmacother; 2023 May; 24(7):835-847. PubMed ID: 37074259 [TBL] [Abstract][Full Text] [Related]
4. [Actual therapeutic options in the treatment of generalized anxiety disorders]. Delini-Stula A; Bondolfi G; Holsboer-Trachsler E Rev Med Suisse; 2010 Jun; 6(255):1370-4. PubMed ID: 20684132 [TBL] [Abstract][Full Text] [Related]
5. Neuropsychological functioning in young subjects with generalized anxiety disorder with and without pharmacotherapy. Tempesta D; Mazza M; Serroni N; Moschetta FS; Di Giannantonio M; Ferrara M; De Berardis D Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():236-41. PubMed ID: 23796524 [TBL] [Abstract][Full Text] [Related]
6. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Algorithm for Generalized Anxiety Disorder. Abejuela HR; Osser DN Harv Rev Psychiatry; 2016; 24(4):243-56. PubMed ID: 27384395 [TBL] [Abstract][Full Text] [Related]
7. New approaches to the pharmacological management of generalized anxiety disorder. Buoli M; Caldiroli A; Caletti E; Paoli RA; Altamura AC Expert Opin Pharmacother; 2013 Feb; 14(2):175-84. PubMed ID: 23282069 [TBL] [Abstract][Full Text] [Related]
10. Generalized anxiety disorder: how to treat, and for how long? Lam RW Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():10-5. PubMed ID: 24931538 [TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin. Both C; Kojda G; Lange-Asschenfeldt C Expert Rev Neurother; 2014 Jan; 14(1):29-38. PubMed ID: 24308277 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of generalized anxiety: new pharmacologic approaches]. Boulenger JP Encephale; 1995; 21(6):459-66. PubMed ID: 8674471 [TBL] [Abstract][Full Text] [Related]
15. Generalized anxiety disorder. Pary R; Matuschka PR; Lewis S; Caso W; Lippmann S South Med J; 2003 Jun; 96(6):581-6. PubMed ID: 12938785 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder. Buoli M; Caldiroli A; Serati M Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):351-359. PubMed ID: 28075650 [TBL] [Abstract][Full Text] [Related]
17. Generalized anxiety disorder: practical assessment and management. Kavan MG; Elsasser G; Barone EJ Am Fam Physician; 2009 May; 79(9):785-91. PubMed ID: 20141098 [TBL] [Abstract][Full Text] [Related]